Fu-Chih Cheng
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
- Co-authors
- Andrea Necchi (1 shared paper)Diana Lüftner (1 shared paper)Matt D. Galsky (1 shared paper)Silvia Foti (1 shared paper)Filippo de Braud (1 shared paper)Zenta Tsuchihashi (1 shared paper)Daniel Barrios (1 shared paper)Bernard Doger (1 shared paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Fu-Chih Cheng
3 papers receiving 80 citations
Peers
Comparison fields: 5 of 13
- Oncology 44
- Surgery 46
- Radiology, Nuclear Medicine and Imaging 14
- Pulmonary and Respiratory Medicine 17
- Urology 2
Countries citing papers authored by Fu-Chih Cheng
This map shows the geographic impact of Fu-Chih Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Chih Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Chih Cheng more than expected).
Fields of papers citing papers by Fu-Chih Cheng
This network shows the impact of papers produced by Fu-Chih Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Chih Cheng. The network helps show where Fu-Chih Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu-Chih Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 73 | |
| 2 | 2024 | 4 | |
| 3 | 2021 | 3 |
About Fu-Chih Cheng
Fu-Chih Cheng is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Immunology and Infectious Diseases, having authored 3 papers that have together received 80 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Lung Cancer Treatments and Mutations (1 paper), Immunotherapy and Immune Responses (1 paper), Urinary and Genital Oncology Studies (1 paper), CAR-T cell therapy research (1 paper), HER2/EGFR in Cancer Research (1 paper) and Esophageal Cancer Research and Treatment (1 paper). The work is most often cited by research in Oncology (44 citations), Surgery (46 citations), Radiology, Nuclear Medicine and Imaging (14 citations), Pulmonary and Respiratory Medicine (17 citations) and Urology (2 citations). Fu-Chih Cheng has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Andrea Necchi, Diana Lüftner, Matt D. Galsky, Silvia Foti, Filippo de Braud, Zenta Tsuchihashi, Daniel Barrios, Bernard Doger, Philip R. Debruyne and Evan Y. Yu. Their work appears in journals such as Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.